Morgan Stanley maintains Overweight on Royalty Pharma; target raised
Morgan Stanley kept Royalty Pharma at Overweight and raised its price target to $67.00 from $65.00.
Story updates
03:12:03 PM UTC
SquawkNews
Royalty Pharma Price Target Raised to $67.00/Share From $65.00 by Morgan Stanley